Eitz Thomas, Fritzsche Dirk, Kleikamp Georg, Zittermann Armin, Horstkotte Dieter, Körfer Reiner
Department of Cardiothoracic Surgery, Heart and Diabetes Center NRW, North-Rhine Westfalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
Ann Thorac Surg. 2006 Oct;82(4):1385-90. doi: 10.1016/j.athoracsur.2006.04.093.
Because of increasing life expectancy of patients with heart valve replacement and a limited durability of heart valve bioprostheses, cardiac reoperation becomes necessary in a significant percentage of patients. Reliable data on mortality and risk factors in octogenarians after replacement of aortic valve prostheses are scanty, however.
We retrospectively analyzed 71 patients aged 80 years and older who underwent cardiac reoperation of the aortic valve (69 bioprostheses, 2 mechanical prostheses) between 1991 and 2004 at our heart center. Survival rate of the study cohort was compared with a control group of octogenarians matched for age, sex, and year of aortic valve replacement. To assess predictors of 30-day survival and 3-year survival, we performed univariate and multivariate analyses.
Survival rates at 30 days, 1 year, 3 years and 5 years were 83.6%, 76.1%, 70.8%, and 51.3%, respectively. Results did not differ significantly between the study cohort and the controls. Patients with reoperation had an estimated median survival of 5.6 years. Postoperative complications such as low cardiac output syndrome and intestinal failure were the only independent predictors of 30-day survival (p = 0.020 and p = 0.015, respectively). Low cardiac output, intestinal failure, and diabetes mellitus were independent predictors of 3-year survival (p = 0.001 to 0.033).
Our data demonstrate that it is possible to achieve an acceptable outcome in octogenarians who have reoperation of the aortic valve prosthesis. Early and mid-term survival is predominantly influenced by unexpected postoperative complications and not by preoperative risk factors, with the exception of diabetes mellitus.
由于心脏瓣膜置换患者的预期寿命增加以及心脏瓣膜生物假体的耐用性有限,相当一部分患者需要进行心脏再次手术。然而,关于八旬老人主动脉瓣置换术后死亡率和危险因素的可靠数据却很少。
我们回顾性分析了1991年至2004年期间在我们心脏中心接受主动脉瓣再次手术的71例80岁及以上患者(69例生物假体,2例机械假体)。将研究队列的生存率与年龄、性别和主动脉瓣置换年份相匹配的八旬老人对照组进行比较。为了评估30天生存率和3年生存率的预测因素,我们进行了单因素和多因素分析。
30天、1年、3年和5年的生存率分别为83.6%、76.1%、70.8%和51.3%。研究队列和对照组之间的结果没有显著差异。再次手术患者的估计中位生存期为5.6年。低心排血量综合征和肠衰竭等术后并发症是30天生存率的唯一独立预测因素(分别为p = 0.020和p = 0.015)。低心排血量、肠衰竭和糖尿病是3年生存率的独立预测因素(p = 0.001至0.033)。
我们的数据表明,八旬老人进行主动脉瓣假体再次手术有可能获得可接受的结果。早期和中期生存率主要受意外术后并发症影响,而非术前危险因素,但糖尿病除外。